• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN MFG SOLUTIONS S.A. DIALYSIS UNKNOWN; CATHETER, PERITONEAL, LONG-TERM INDWELLING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN MFG SOLUTIONS S.A. DIALYSIS UNKNOWN; CATHETER, PERITONEAL, LONG-TERM INDWELLING Back to Search Results
Model Number DIALYSIS UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Thrombosis/Thrombus (4440)
Event Date 09/28/2021
Event Type  Injury  
Manufacturer Narrative
Concomitant medical products:¿ dialysis unknow (lot#: unknown); dialysis unknow (lot#: unknown) title: tunneled femoral vein catheterization for long-term hemodialysis ¿ experience from a tertiary care center source: indian journal of nephrology; volume 32; issue 4.Date of publication: 20-05-2022.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
According to the literature, a retrospective study between january 2020 and april 2021 evaluated the efficacy, catheter life, and long-term complications of tunneled hemodialysis catheters placed in the common femoral vein due to optimal vascular access exhaustion.Twenty-one patients were included in the study where either a palindrome or competitor hemodialysis catheter was placed.Right sided femoral catheter insertion was performed in 18 patients (85.7%) and 3 patients underwent left-sided insertion.All patients received intravenous vancomycin (1 g) on the day of procedure and the skin preparation was done with 10% povidone iodine.All the catheters were inserted under real-time ultrasonographical guidance under strict septic conditions.Reported complications included catheter-related infection in 3 patients where the catheter had to be removed and 3 cases of catheter-related deep venous thrombosis (dvt).Two other patients developed iliac and femoral vein thrombosis that extended into the inferior vena cava at 1 month for which the catheters were removed and anticoagulation was started.Patients with probable catheter-related blood stream infections were started on intravenous vancomycin and piperacillin tazobactam that was later modified as per the blood culture sensitivity report.Patients who presented with limb edema after catheterization, a duplex ultrasonography was done for deep venous thrombosis and were anticoagulated with warfarin after catheter removal.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DIALYSIS UNKNOWN
Type of Device
CATHETER, PERITONEAL, LONG-TERM INDWELLING
Manufacturer (Section D)
COVIDIEN MFG SOLUTIONS S.A.
edificio b20, calle #2
alajuela 20101
CS  20101
Manufacturer (Section G)
COVIDIEN MFG SOLUTIONS S.A.
edificio b20, calle #2
alajuela 20101
CS   20101
Manufacturer Contact
justin ellis
8200 coral sea st ne
mounds view, MN 55112
7635265677
MDR Report Key15792357
MDR Text Key303627502
Report Number3009211636-2022-00400
Device Sequence Number1
Product Code FJS
Combination Product (y/n)N
Reporter Country CodeIN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Other
Type of Report Initial
Report Date 11/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberDIALYSIS UNKNOWN
Device Catalogue NumberDIALYSIS UNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/28/2022
Initial Date FDA Received11/14/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age45 YR
-
-